Eugene Baranov, Ph.D.

San Diego, CA ad333w@r.postjobfree.com 858-***-****

Scientific Development Executive with 25+ years of experience in stem cell and cancer research. History of consistent success leading improvement in scientific discovery, preclinical, and clinical operations. Experience championing innovative applications in stem cells and stem cell-derived products, translating research discovery results into commercial pipeline products, and establishing impactful scientific teams. Authored and published 20+ papers in peer- reviewed journals along with securing multiple patents. Areas of Expertise

• Strategic Scientific Leadership

• Stem Cell and Cancer Research

• Anti-Aging Research

• Regulatory Compliance

• Scientific Team Leadership

• Technology Transfer

• Project Management

• Laboratory Practices

• External Representation

• Quality Assurance

Professional Experience

Managing Director/CEO

AntiCA Biomed, San Diego, CA Sep 2020 – Present

• Co-founded and provided scientific leadership for an international biomedical company specializing in the development of a novel type of cancer treatment, leading the research team in developing a next-generation therapy with a novel type of immune-modulating formula that targets previously unexplored immune mechanisms in preclinical models, offering an advantage over IPSC-based vaccine.

• Led the development of systemic anti-aging therapies by leveraging the potential of both stem cells and stem cell- derived products, evaluating efficacy through comprehensive analysis, including blood markers, physiological aging indicators, and epigenetic age measurements.

• Managed a dynamic team of Scientists and R&D Specialists, providing oversight for project responsibilities, facilitating status reports, and collaborating with multiple Contract Research Organizations (CROs).

• Prepare and administer annual operating budget, established financial management system, outlined budgeting, forecasting, and reporting processes, outline yearly and one-time project costs, renegotiate contracts with key vendors, and optimize materials and labor spending. Research Consultant May 2019 – Present

Vice President of Global Research Oct 2005 – May 2019 Stemedica Cell Technologies, San Diego, CA

• Spearheaded scientific research operations for clinical-stage biopharmaceutical company focused on the development and commercialization of stem cell and stem cell-derived therapeutics for underserved medical conditions.

• Supervised and delivered clinical data for over 300 treated patients with various types of pathologies and medical conditions, contributing to the company's successful securing of $120 million in capital.

• Commended for launching first clinical trials of patients with Acute Myocardial Infarction in Kazakhstan, which was subsequently officially approved as a treatment in the country.

• Partnered with Executive leadership to develop initial scientific operations, established vital stem cell center, grew strategic relationships within stem cell research field and CROs, and outlined transfer of developed bone marrow stem cell-based technologies from those research groups, filed joint patents, and conducted pilot clinical studies overseas.

• Managed preclinical testing planning, operations, and teams, focused on development and research of stem cells along with stem cell-derived products, partnered with executive leadership to develop ideal lab operations, established cell facility, biobanking various types of stem cells ((bone marrow, umbilical cord, placenta, neural progenitor cells etc.) and setting up successful human trials.

• Led scientific due diligence by conducting extensive literature research, designed, and executed cell applications to determine efficacy, supervised global CROs, created program management budgets, timelines, and tasks, oversaw data, and produced effective presentations for investors and stakeholders.

• Streamlined scientific and preclinical operations, developed specific duty assignment system for sperate groups, created project check and priority lists of different projects, and established review meetings to champion culture of continuous improvement; showcased preclinical data that secured approval for clinical treatment of targeted patients.

• Project managed overseas clinical trials for patients with cardiovascular and neurodegenerative diseases, outlined safety and efficacy of applied stem cells for treatment, developed required paperwork required by FDA for IND submission, and served as key contact for all government and regulatory bodies; reduced cost of stem cell testing by managing multiple preclinical studies. This currently permits the Company to progress to Phase II and IIb/III clinical trials for two indications.

• Directly consulted with Executive, Business Development, and Legal leadership, contributed to initiatives to transfer intellectual property (IP) from overseas patents, including technology isolation and processing of bone marrow derived and neuronal progenitor stem cells, successfully secured US patents, and enabled company to speed up time to market.

Vice President of Research

Biopharma Scientific, Inc., San Diego, CA Feb 2005 – Oct 2005

• Spearheaded the development of nutritional supplement formulas, creating new blends that incorporate a diverse range of health-promoting ingredients. Ensured an exceptional taste experience for consumers, leading to extensive sales, including placement in Costco stores nationwide.

• Oversaw development and successfully implemented products into the commercial market through intelligent development and improved non-invasive skin imaging technology by using novel development quantitate approach. Director of Research

Biohydration Research Lab, Carlsbad, CA Mar 2002 – Feb 2005

• Managed research, including product testing at clinical, cellular and molecular levels for production of ultra-purified, high-quality drinking water utilizing proprietary scientific and manufacturing technology.

• Project managed multiple studies from molecular to cell levels showing benefits of novel developed product, presented research results at the International Conferences, and developed improved scientific and sales documentation to provide impactful tools for Sales Team; received "Manager of the Year" award for contributions. Research Scientist

AntiCancer, Inc., San Diego, CA Sep 1996 – Mar 2002

• Developed whole-body imaging technology for visualization of gene expression, pioneered preclinical tumor imaging technology for drug efficacy evaluation in extensive preclinical testing, and secured several patents by developing innovative technology: increased product orders after developing a noninvasive, cost-efficient method for assessing tumor growth in testing anticancer drugs.

Visiting Professor

University of NSW, Sydney, Australia Jan 1993 – Sep 1996

• Conducted an in-depth analysis of the molecular structure of breast cancer specimens using low-angle X-ray diffraction method. Novel double-derivative method was developed to efficiently process image data from various biological tissues, demonstrating a significant advancement in the field of cancer research. The research not only provided valuable insights into the molecular composition of breast cancer, but also showcased a pioneering approach to data processing, underscoring its potential for substantial impact for cancer patients and scientific community.

Education

Ph.D. in Biophysics, Thesis: "Molecular and Cellular Mechanisms of Action of the Anticancer Drug Doxorubicin and Its Derivatives"

Master of Science, Specialty in Molecular Physics of Fast Chemical Processes Moscow Institute of Physics and Technology, Moscow, Russia

Contact this candidate